Active Motif acquires Amaryllis Nucleics

By The Science Advisory Board staff writers

January 28, 2022 -- Active Motif has purchased Amaryllis Nucleics, a startup focused on proprietary RNA sequencing methods.

Amaryllis provides Active Motif with a streamlined, low-cost library preparation method to perform high-efficiency RNA sequencing using its intellectual property associated with 3' digital gene expression, said Active Motif. The technology uses novel synthesis chemistry, which the company said is twice as fast from RNA to library prep compared to other methods, is less expensive, and shows greater than 99% strand specificity.

Amaryllis' service business and its 3' DGE RNA Library Prep Kit will be integrated into the Active Motif portfolio, according to the firm.

Financial details of the acquisition were not disclosed.

Active Motif is focused on bringing epigenetics more deeply into precision medicine.

Active Motif partners with Arima Genomics to provide Hi-C service
Active Motif, a company focused on epigenetics-based research tools and services, has launched an end-to-end Hi-C service in partnership with Arima Genomics,...

Copyright © 2022

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter